Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in alzheimer’s disease
- 1 August 2002
- journal article
- early detection-of-cognitive-impairment
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 19 (1-2) , 7-10
Abstract
Development of probes for β-amyloid (Aβ) plaques, a critical factor associated with Alzheimer’s disease (AD), provides important tools for studying their role in AD. Previously, we reported [125I]IMSB and [125I]ISB as excellent probes for Aβ plaque labeling. Despite their exquisite in vitro binding characteristics, low brain uptakes (likely due to two ionizable carboxylic acid groups) limited their potential as in vivo imaging agents. To improve brain penetration, we have successfully prepared a neutral radioiodinated probe [125I]3. The improved probe displayed good binding affinity for Aβ aggregates (Ki=2.0 ± 0.2 using Aβ40 aggregates). In addition, the brominated counterpart displayed fluorescent-staining properties of Aβ plaques in postmortem AD brain sections similar to BSB, a fluoroscent probe reported previously. [125I]3 gave excellent plaque labeling by film autoradiography of AD brain sections. Unlike [125I]IMSB (which preferentially detects Aβ40 plaques), the improved radioioinated probe, [125I]3, can readily detect plaques containing aggregates of both Aβ40 and Aβ42. The initial brain uptake of [125I]3 in normal mice at 2 min p.i. was moderate (0.18% ID) and displayed a very slow washout from the brain (0.11 %.ID at 4 h p.i). Taken together, these data suggest that [125I]3 is useful for in vitro plaque detection, it may not be suitable for in vivo monitoring of Aβ progression and deposition.Keywords
This publication has 14 references indexed in Scilit:
- The Fluorescent Congo Red Derivative, (Trans, Trans)−1-Bromo-2,5-Bis-(3-Hydroxycarbonyl-4-Hydroxy)Styrylbenzene (BSB), Labels Diverse β-Pleated Sheet Structures in Postmortem Human Neurodegenerative Disease BrainsThe American Journal of Pathology, 2001
- In vitro and in vivo binding characteristics of two biological probes for plaques and tangles in alzheimer's diseaseJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- Lipophilic 11C‐labelled thioflavin‐T analogues for imaging amyloid plaques in alzheimer's diseaseJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- Imaging Alzheimer's amyloidNature Biotechnology, 2000
- Aβ1-40 Peptide Radiopharmaceuticals for Brain Amyloid Imaging: 111In Chelation, Conjugation to Poly(ethylene glycol)-Biotin Linkers, and Autoradiography with Alzheimer's Disease Brain SectionsBioconjugate Chemistry, 2000
- 99m Tc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Aβ−42 deposition precedes other changes in PS-1 Alzheimer's diseaseThe Lancet, 1998
- Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probeNeurobiology of Aging, 1995
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992